title: Tdap vaccination coverage during pregnancy, active component service women, 2006-2014.
abstract: Tetanus, diphtheria, and acellular pertussis (Tdap) vaccines have been licensed for use in the U.S. since 2006 and have been recommended during pregnancy since 2011. Low vaccination coverage during pregnancy among the general U.S. population has been reported. Therefore, this surveillance study was conducted to assess the percentage of service women with a live birth delivery during 2006-2014 who received a Tdap vaccination during their pregnancy. Only 1%-3% of service women during 2006-2011 received a Tdap vaccine during their pregnancy. However, coverage increased to 8% in 2012 and 54% in 2014. Although this moderate Tdap coverage among military service women is an improvement over past years, more education and attention by military physicians and pregnant service women to the benefits of Tdap vaccination are needed to bring coverage closer to 100%.
authors.forename: Angelia A
authors.initials: AA
authors.lastname: Eick-Cost
authors.forename: Zheng
authors.initials: Z
authors.lastname: Hu
mesh_terms: D000328:Adult; D004165:Diphtheria / Q000453:epidemiology / Q000517:prevention & control*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017589:Immunization Programs; D008889:Military Personnel; D017063:Outcome Assessment, Health Care; D011159:Population Surveillance; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000517:prevention & control*; D011256:Pregnancy Outcome / Q000453:epidemiology; D013742:Tetanus / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States / Q000453:epidemiology; D014917:Whooping Cough / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines